Sitewide
2 drugs equally effective for heart patients undergoing angioplasty, Mayo study finds
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide?
Similar Articles On This Topic:
- Mayo Clinic study finds that after heart attack most patients stop taking life-saving drugs
- Drug therapy more cost-effective than angioplasty for diabetic patients with heart disease
- Double doses of clopidogrel better than standard doses for heart patients undergoing angioplasty
- Heart bypass surgery better than angioplasty for certain patients, Stanford study shows
- Florida study finds barriers to angioplasty for life-threatening heart attacks
Popular Today:
Science 2.0:
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment